AI predicting brain cancer relapse represents a groundbreaking advancement in pediatric oncology, particularly in managing cases of glioma.A recent study conducted by researchers at Mass General Brigham demonstrated that an AI tool could analyze multiple brain scans over time, achieving significantly higher accuracy in predicting cancer recurrence compared to traditional methods.